DrugPatentWatch Database Preview
Drugs in Development Information for Deoxythymidine
Email this page to a colleague
See Plans and PricingWhat is the development status for investigational drug Deoxythymidine?
Deoxythymidine is an investigational drug.
There have been 8 clinical trials for Deoxythymidine.
The most recent clinical trial was a Phase 2 trial.
The most common disease conditions in clinical trials are HIV Infections, Infection, and Communicable Diseases. The leading clinical trial sponsors are National Institute of Allergy and Infectious Diseases (NIAID), Bristol-Myers Squibb, and Muscular Dystrophy Association.
Summary for Deoxythymidine
| US Patents | 0 |
| International Patents | 0 |
| US Patent Applications | 4,160 |
| WIPO Patent Applications | 2,821 |
| Japanese Patent Applications | 4 |
| Clinical Trial Progress | Phase 2 (1969-12-31) |
| Vendors | 79 |
Recent Clinical Trials for Deoxythymidine
| Title | Sponsor | Phase |
|---|---|---|
| An Open-Label Study of Continuation Treatment With Combination Pyrimidine Nucleosides in Patients With TK2 | Modis Therapeutics, Inc. | Phase 2 |
| Treatment of TK2 Deficiency With Thymidine and Deoxycytidine | Centro de Investigación Biomédica en Red Enfermedades Raras (CIBERER), Spain | Phase 1/Phase 2 |
| Treatment of TK2 Deficiency With Thymidine and Deoxycytidine | Hospital Universitario 12 de Octubre | Phase 1/Phase 2 |
Clinical Trial Summary for Deoxythymidine
Top disease conditions for Deoxythymidine
Top clinical trial sponsors for Deoxythymidine
US Patents for Deoxythymidine
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
